20 articles
New research reveals uric acid actively causes obesity by depleting a key gut bacterium and unleashing intestinal fat absorption — not just a bystander.
New research reveals how excess salt intake aggravates prostate inflammation by altering gut bacteria and immune cell function.
A new review links adult cholestasis to pediatric genetic syndromes, opening doors to targeted therapies including novel bile acid transport inhibitors.
Go beyond probiotics and fiber — explore the cutting-edge science of fecal microbiota transplantation, engineered postbiotics, and how the gut orchestrates systemic aging through immune and neural circuits.
Small pilot study explores whether restoring gut bacteria can break the cycle of recurrent UTIs in women.
Middle-aged woman's submucosal rectal lesion demonstrates critical need for precise endoscopic evaluation methods.
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
WES identified a genetic diagnosis in nearly 1 in 4 adults with unexplained cholestatic liver disease, including genes beyond the classic PFIC spectrum.
New research reveals how androgen deprivation therapy disrupts gut microbiome and bile acids, causing memory problems through brain signaling pathways.
Researchers develop innovative fluorescent approach to combat chronic hepatitis E, offering new hope for treatment-resistant infections.
A completed clinical trial tests whether a prebiotic blend can boost Akkermansia muciniphila and support weight management in metabolic syndrome.
A comprehensive review reveals how SCFAs, bile acids, and tryptophan metabolites reshape the tumor immune microenvironment in GI cancers.
New research reveals how specific gut microbes modify bile acids through hydroxylation, potentially reducing colorectal cancer development.
New research reveals how disrupted gut microbiome and bile acid metabolism increase cancer risk in PSC patients.
Scientists develop gut-targeted compound that protects liver and boosts nutrient absorption after small bowel surgery, offering hope where no treatments exist.
Synthetic biology meets the microbiome: designer probiotics restore gut-liver-brain balance better than rifaximin in preclinical models.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
A completed pilot trial explores whether a cholesterol-lowering probiotic can improve cardiometabolic health in people with celiac disease.
Researchers identify Limousia bacteria with unique molecular machinery for degrading intestinal mucus, revealing new microbe-host interactions.
New research reveals intelectin-2 protein strengthens gut mucus while directly neutralizing harmful bacteria, including antibiotic-resistant strains.
Study shows probiotic bacteria shields heart muscle from toxic effects of cancer chemotherapy through metabolite pathway.
